<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with<sup>18</sup>F-FDG
Brad Kline(University of California, San Francisco), Thomas A. Hope(Fondazione IRCCS Istituto Nazionale dei Tumori), Robin Kate Kelley(UCSF Helen Diller Family Comprehensive Cancer Center), Spencer C. Behr(University of California, San Francisco), Courtney Lawhn-Heath(University of California, San Francisco), Robin Cumming Ippisch(University of California, San Francisco), Patrick K. Ha(University of California, San Francisco), Youngho Seo(University of California, San Francisco), Rahul Aggarwal(UCSF Helen Diller Family Comprehensive Cancer Center), Robert R. Flavell(University of California, San Francisco), Sue S. Yom(University of California, San Francisco), Hope S. Rugo(City of Hope), Victoria Wang(IIT@Harvard), Fei Jiang(University of California, San Francisco), Michelle Melisko(University of California, San Francisco), Surekha Yadav(University of California, San Francisco), Jessa B. Castillo(University of California, San Francisco)
Cited by 36
Related Papers
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k